The University of Michigan is one of the largest
and broadest based Transplant Centers in the country,
performing more than 400 solid organ transplants yearly.
Furthermore, over 200 adult and pediatric stem cell
transplants (bone marrow transplants) are performed
annually. While patient outcomes are generally excellent,
many of these patients have to take medications to
prevent rejection of their transplanted organ or to
prevent “graft versus host disease.” This
suppression of the immune system makes organ and bone
marrow transplant recipients susceptible to a variety
of infections. The transplant infectious disease service
works closely with the transplant surgeons and many
other medical specialists involved in the care of
these complex patients to both treat and prevent infections.